Published in Am J Psychiatry on January 01, 2002
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience (2010) 1.05
EEG: a helpful tool in the prediction of psychosis. Eur Arch Psychiatry Clin Neurosci (2009) 0.87
EEG alterations during treatment with olanzapine. Eur Arch Psychiatry Clin Neurosci (2011) 0.84
Electroencephalographic abnormalities in clozapine-treated patients: a cross-sectional study. Psychiatry Investig (2011) 0.83
Aberrant functional organization and maturation in early-onset psychosis: evidence from magnetoencephalography. Psychiatry Res (2007) 0.82
Factors associated with response to clozapine in schizophrenia: a review. Psychopharmacol Bull (2011) 0.82
Predictors and markers of clozapine response. Psychopharmacology (Berl) (2005) 0.82
Oscillatory cortical network involved in auditory verbal hallucinations in schizophrenia. PLoS One (2012) 0.80
Neural processing of emotional facial and semantic expressions in euthymic bipolar disorder (BD) and its association with theory of mind (ToM). PLoS One (2012) 0.79
Late-onset seizures associated with quetiapine poisoning. J Med Toxicol (2009) 0.78
Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia. Neuropsychiatr Dis Treat (2014) 0.78
Multivariate genetic determinants of EEG oscillations in schizophrenia and psychotic bipolar disorder from the BSNIP study. Transl Psychiatry (2015) 0.78
EEG changes with antipsychotic drugs. Am J Psychiatry (2002) 0.78
Resting EEG deficits in accused murderers with schizophrenia. Psychiatry Res (2011) 0.76
Drug Treated Schizophrenia, Schizoaffective and Bipolar Disorder Patients Evaluated by qEEG Absolute Spectral Power and Mean Frequency Analysis. Clin Psychopharmacol Neurosci (2014) 0.76
Joint Coupling of Awake EEG Frequency Activity and MRI Gray Matter Volumes in the Psychosis Dimension: A BSNIP Study. Front Psychiatry (2015) 0.75
Clozapine response and pre-treatment EEG-is there some kind of relationship. Ind Psychiatry J (2014) 0.75
Low-dose Clozapine-induced Seizure: A Case Report. Clin Psychopharmacol Neurosci (2017) 0.75
Inefficient Preparatory fMRI-BOLD Network Activations Predict Working Memory Dysfunctions in Patients with Schizophrenia. Front Psychiatry (2016) 0.75
EEG Abnormalities in a patient taking Aripiprazole. Psychiatry (Edgmont) (2007) 0.75
Electroencephalography Spectral Power Density in First-Episode Mania: A Comparative Study with Subsequent Remission Period. Noro Psikiyatr Ars (2015) 0.75
Olanzapine-induced electroencephalographic changes reversed by lamotrigine. Ann Indian Acad Neurol (2012) 0.75
Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder. Neuropsychiatr Dis Treat (2017) 0.75
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry (2004) 3.76
The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord (2005) 3.74
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry (2007) 3.40
International consensus study of antipsychotic dosing. Am J Psychiatry (2010) 3.39
Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry (2004) 3.26
The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry (2003) 3.25
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry (2003) 3.00
Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord (2006) 2.74
Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry (2008) 2.44
Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes (2006) 2.42
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39
A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord (2003) 2.03
Modern antipsychotic drugs: a critical overview. CMAJ (2005) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause (2002) 1.92
Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry (2004) 1.90
Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years. J Pers Disord (2005) 1.85
Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders. Am J Psychiatry (2003) 1.84
A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett (2004) 1.79
Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res (2005) 1.77
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord (2003) 1.74
Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry (2002) 1.62
Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry (2006) 1.60
Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder. Harv Rev Psychiatry (2002) 1.60
Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom (2013) 1.50
Effects of newer antipsychotics on extrapyramidal function. CNS Drugs (2002) 1.50
ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology (2006) 1.49
Precursors of bipolar disorders: a systematic literature review of prospective studies. J Clin Psychiatry (2015) 1.49
Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry (2002) 1.49
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry (2007) 1.49
Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv (2007) 1.48
Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010. Psychother Psychosom (2013) 1.46
Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46
Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46
Memory dysfunction. N Engl J Med (2005) 1.46
Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry (2004) 1.43
Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trial. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.43
Integration of suicidology with general medicine: an obligation to society. Patient Educ Couns (2011) 1.42
Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord (2010) 1.41
Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry (2002) 1.40
Disability and its treatment in bipolar disorder patients. Bipolar Disord (2007) 1.39
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39
The role of psychotic disorders in religious history considered. J Neuropsychiatry Clin Neurosci (2012) 1.38
Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev (2003) 1.36
Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord (2008) 1.35
Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci (2006) 1.35
Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry (2007) 1.28
Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology (2010) 1.28
Suicide risk and treatments for patients with bipolar disorder. JAMA (2003) 1.26
Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry (2006) 1.24
Suicide rates in relation to health care access in the United States: an ecological study. J Clin Psychiatry (2006) 1.22
Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv (2003) 1.19
Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord (2006) 1.18
Reported childhood onset of self-mutilation among borderline patients. J Pers Disord (2006) 1.18
Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology (2011) 1.18
Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry (2007) 1.17
Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients. J Nerv Ment Dis (2002) 1.17
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial. Clin Neuropharmacol (2010) 1.16
Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry (2002) 1.14
Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry (2011) 1.14
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2008) 1.13
Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2007) 1.12
Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive? Expert Opin Biol Ther (2013) 1.12
Smaller frontal lobe white matter volumes in depressed adolescents. Biol Psychiatry (2002) 1.11
McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2010) 1.11
Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord (2004) 1.11
Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review. Harv Rev Psychiatry (2002) 1.11
Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry (2004) 1.10
Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res (2004) 1.10
Advances in development of dopaminergic aporphinoids. J Med Chem (2007) 1.10
Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol (2013) 1.10
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord (2006) 1.08
Adult experiences of abuse reported by borderline patients and Axis II comparison subjects over six years of prospective follow-up. J Nerv Ment Dis (2005) 1.08
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol (2006) 1.07
Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet (2003) 1.07
Genetics of suicide: an overview. Harv Rev Psychiatry (2004) 1.07
Manic-depressive illness: evolution in Kraepelin's Textbook, 1883-1926. Harv Rev Psychiatry (2005) 1.06
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biol Psychiatry (2002) 1.06
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol (2003) 1.06
Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry (2005) 1.04
Shape differences in the corpus callosum in first-episode schizophrenia and first-episode psychotic affective disorder. Am J Psychiatry (2002) 1.04
Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Res (2003) 1.04
Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev (2013) 1.03
Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors. Pharmacol Ther (2011) 1.03
A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study. Neuropsychopharmacology (2005) 1.02
Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. J Pers Disord (2004) 1.00
An ongoing study of group treatment for men involved in problematic Internet-enabled sexual behavior. Cyberpsychol Behav (2006) 1.00
Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry (2007) 0.99
Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry (2006) 0.98
Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc (2009) 0.98
The functional neuroanatomy of decision-making. J Neuropsychiatry Clin Neurosci (2012) 0.98
Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord (2003) 0.98
Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacology (Berl) (2002) 0.98
Magnetic resonance imaging-guided stereotactic limbic leukotomy for treatment of intractable psychiatric disease. Neurosurgery (2002) 0.97